Released Nov 12, 2020, before the open
10-Q filed Nov 12, 2020, 43 days after period end · 0001558370-20-013741
Q3 2020 · 10-Q
Revenue$0.00$0.00 — vs Q3 2019no prior Q2 2020 on file
Net Income-$2.26M-$2.26M N/M vs Q3 2019N/M vs Q2 2020
EPS Diluted-$0.47-$0.47 N/M vs Q3 2019N/M vs Q2 2020
Operating Income-$2,572,000N/M
Operating Cash Flowderived-$2,129,000N/M
Free Cash Flowderived-$2,179,000N/M
What the release said
The release
Same quarter
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.26M | -$1.90M | -$2.07M | -$1.86M |
| EPS Diluted | -$0.47 | -$2.27 | -$0.18 | -$0.91 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Green Med Solution, Inc. · CIK 1130166 · Engraved from SEC EDGAR